Primary |
Product Used For Unknown Indication |
31.0% |
Depression |
13.1% |
Pain |
6.3% |
Overdose |
6.0% |
Hypertension |
5.6% |
Intentional Overdose |
4.5% |
Neuralgia |
4.1% |
Antidepressant Therapy |
3.4% |
Headache |
3.4% |
Insomnia |
3.4% |
Migraine |
2.6% |
Bacteraemia |
2.2% |
Fibromyalgia |
2.2% |
Anxiety |
1.9% |
Arthralgia |
1.9% |
Drug Use For Unknown Indication |
1.9% |
Hypothyroidism |
1.9% |
Sleep Disorder |
1.9% |
Analgesic Therapy |
1.5% |
Back Pain |
1.5% |
|
Toxicity To Various Agents |
15.7% |
Overdose |
7.1% |
Somnolence |
7.1% |
Syncope |
7.1% |
Serotonin Syndrome |
5.7% |
Status Epilepticus |
5.7% |
Withdrawal Syndrome |
5.7% |
Bundle Branch Block Left |
4.3% |
Drug Ineffective |
4.3% |
Electrocardiogram Qt Prolonged |
4.3% |
Renal Aplasia |
4.3% |
Suicidal Ideation |
4.3% |
Ventricular Tachycardia |
4.3% |
Death |
2.9% |
Drug Exposure During Pregnancy |
2.9% |
Dry Mouth |
2.9% |
Familial Hypocalciuric Hypercalcaemia |
2.9% |
Foetal Growth Restriction |
2.9% |
Hyponatraemia |
2.9% |
Myocardial Ischaemia |
2.9% |
|
Secondary |
Product Used For Unknown Indication |
50.7% |
Drug Use For Unknown Indication |
11.7% |
Drug Abuse |
6.6% |
Depression |
5.7% |
Pain |
5.3% |
Hypertension |
2.9% |
Neuralgia |
2.3% |
Intentional Overdose |
1.6% |
Migraine |
1.5% |
Anxiety |
1.4% |
Insomnia |
1.2% |
Sleep Disorder |
1.1% |
Suicide Attempt |
1.1% |
Bacteraemia |
1.1% |
Rheumatoid Arthritis |
1.1% |
Back Pain |
1.1% |
Major Depression |
1.0% |
Myelitis Transverse |
0.9% |
Fibromyalgia |
0.9% |
Hiv Infection |
0.8% |
|
Completed Suicide |
19.1% |
Toxicity To Various Agents |
14.5% |
Respiratory Arrest |
10.0% |
Death |
9.3% |
Drug Abuse |
9.1% |
Poisoning |
4.3% |
Syncope |
4.0% |
Drug Hypersensitivity |
3.4% |
Somnolence |
3.3% |
Vomiting |
3.0% |
Weight Increased |
3.0% |
Unresponsive To Stimuli |
2.6% |
Intentional Drug Misuse |
2.4% |
Cardio-respiratory Arrest |
2.3% |
Drug Ineffective |
1.9% |
Suicide Attempt |
1.9% |
Serotonin Syndrome |
1.6% |
Suicidal Ideation |
1.6% |
Tremor |
1.6% |
Overdose |
1.4% |
|
Concomitant |
Product Used For Unknown Indication |
30.4% |
Drug Use For Unknown Indication |
14.3% |
Pain |
8.4% |
Depression |
6.4% |
Rheumatoid Arthritis |
6.3% |
Hypertension |
5.9% |
Anxiety |
3.0% |
Insomnia |
2.6% |
Sleep Disorder |
2.3% |
Gastrooesophageal Reflux Disease |
2.3% |
Crohn's Disease |
2.2% |
Migraine |
2.1% |
Diabetes Mellitus |
2.1% |
Fibromyalgia |
2.0% |
Multiple Sclerosis |
2.0% |
Asthma |
1.8% |
Blood Cholesterol Increased |
1.6% |
Neuralgia |
1.6% |
Back Pain |
1.5% |
Osteoporosis |
1.3% |
|
Vomiting |
12.6% |
Weight Decreased |
11.5% |
Weight Increased |
10.9% |
Pain |
6.3% |
Pulmonary Embolism |
5.0% |
Type 2 Diabetes Mellitus |
4.8% |
Nausea |
4.2% |
Pain In Extremity |
3.9% |
Vision Blurred |
3.8% |
Rash |
3.7% |
Drug Ineffective |
3.6% |
Pneumonia |
3.6% |
Urinary Tract Infection |
3.6% |
Renal Failure Acute |
3.5% |
Tremor |
3.4% |
Wrong Technique In Drug Usage Process |
3.4% |
Death |
3.2% |
Suicidal Ideation |
3.2% |
Headache |
3.0% |
Pruritus |
2.8% |
|
Interacting |
Product Used For Unknown Indication |
18.0% |
Pain |
17.5% |
Parkinson's Disease |
13.3% |
Depression |
9.5% |
Back Pain |
7.1% |
Sleep Disorder |
4.7% |
Major Depression |
3.8% |
Dyspepsia |
3.3% |
Schizophrenia |
3.3% |
Hypertension |
2.8% |
Neuralgia |
2.8% |
Insomnia |
2.4% |
Arthritis |
1.4% |
Fibromyalgia |
1.4% |
Hiv Infection |
1.4% |
Hypercholesterolaemia |
1.4% |
Hypersensitivity |
1.4% |
Hypothyroidism |
1.4% |
Limb Injury |
1.4% |
Muscle Spasms |
1.4% |
|
Nausea |
16.7% |
Toxicity To Various Agents |
14.8% |
Tremor |
9.3% |
Drug Interaction |
7.4% |
Respiratory Arrest |
7.4% |
Visual Impairment |
7.4% |
Serotonin Syndrome |
5.6% |
Weight Decreased |
5.6% |
Advanced Sleep Phase |
3.7% |
Extrapyramidal Disorder |
3.7% |
Hallucination, Visual |
1.9% |
Hepatic Enzyme Increased |
1.9% |
Lactic Acidosis |
1.9% |
Mental Status Changes |
1.9% |
Musculoskeletal Stiffness |
1.9% |
Pulmonary Oedema |
1.9% |
Respiratory Depression |
1.9% |
Sedation |
1.9% |
Septic Shock |
1.9% |
Sluggishness |
1.9% |
|